Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University
• Treatments: Fluorouracil

Criteria

Inclusion Criteria:

• Any male or female 50 years of age or older with moderate to severe actinic keratoses of the face and anterior scalp diagnosed by a dermatologist will be eligible for participation.

Exclusion Criteria:

• Age less than 50.

• Known allergy or sensitivity to topical Carac® in the subject.

• Inability to complete all study-related visits.

• Introduction of any other prescription medication, topical or systemic, for actinic keratosis while participating in the study.

• Subjects should not receive surgical or cryotherapy while participating in the study.

• Pregnant women, women who are breast feeding, or women of child bearing potential who are not practicing two acceptable methods of birth control